Beneficial effects of sodium-glucose cotransporter 2 inhibitors for preservation of pancreatic β -cell function and reduction of insulin resistance-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Beneficial effects of sodium-glucose cotransporter 2 inhibitors for preservation of pancreatic β -cell function and reduction of insulin resistance

Published:2016-12-01 Issue:3 Volume:9 Page:219-225
ISSN:1753-0393
Container-title:Journal of Diabetes
language:en
Short-container-title:J Diabetes

Author:

Kaneto Hideaki¹,Obata Atsushi¹,Kimura Tomohiko¹,Shimoda Masashi¹,Okauchi Seizo¹,Shimo Naoki²,Matsuoka Taka-aki²,Kaku Kohei³

Affiliation:

1. Departments of Diabetes, Endocrinology and Metabolism; Kawasaki Medical School; Kurashiki Japan

2. Department of Metabolic Medicine; Osaka University Graduate School of Medicine; Osaka Japan

3. General Internal Medicine 1; Kawasaki Medical School; Kurashiki Japan

Publisher

Wiley

Subject

Endocrinology, Diabetes and Metabolism

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/1753-0407.12494/fullpdf

Reference52 articles.

1. Insulin signalling and the regulation of glucose and lipid metabolism;Saltiel;Nature,2001

2. Cellular mechanisms of insulin resistance;Shulman;J Clin Invest,2000

3. β-Cell adaptation and decompensation during the progression of diabetes;Weir;Diabetes,2001

4. The human kidney low affinity Na+/glucose cotransporter SGLT2. Delineation of the major renal reabsorptive mechanism for d-glucose;Kanai;J Clin Invest,1994

5. SGLT2 inhibition - a novel strategy for diabetes treatment;Chao;Nat Rev Drug Discov,2010

Cited by 59 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. SGLT2 inhibitors for the treatment of diabetes: a patent review (2019–23);Expert Opinion on Therapeutic Patents;2024-08-02

2. The effect of sodium‐glucose cotransporter‐2 inhibitors on inflammatory biomarkers: A meta‐analysis of randomized controlled trials;Diabetes, Obesity and Metabolism;2024-04-11

3. The Efficacy and Safety of Astragalus as an Adjuvant Treatment for Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis;Journal of Integrative and Complementary Medicine;2024-01-01

4. Remission effect of Canagliflozin in patients with newly diagnosed type 2 diabetes mellitus: a protocol for a multicenter, parallel-group, randomized, controlled, open-label trial;BMC Endocrine Disorders;2023-10-10

5. Empagliflozin improves insulin sensitivity in patients with recent acute coronary syndrome and newly detected dysglycaemia;Cardiovascular Diabetology;2023-08-11

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3